Followers | 805 |
Posts | 30007 |
Boards Moderated | 7 |
Alias Born | 03/22/2016 |
Thursday, March 21, 2024 11:07:43 AM
Recent TRVI News
- Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024 • PR Newswire (US) • 05/01/2024 08:05:00 PM
- FNB Harvest annonce les distributions d’avril 2024 • Business Wire • 04/23/2024 11:30:00 AM
- Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference • PR Newswire (US) • 04/09/2024 11:30:00 AM
- Trevi Therapeutics to Participate in Upcoming April Events • PR Newswire (US) • 04/04/2024 11:30:00 AM
- Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team • PR Newswire (US) • 04/02/2024 11:30:00 AM
- FNB Harvest annonce les distributions de mars 2024 • Business Wire • 03/21/2024 11:30:00 AM
- Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates • PR Newswire (US) • 03/20/2024 08:05:00 PM
- Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024 • PR Newswire (US) • 03/13/2024 08:05:00 PM
- Trevi Therapeutics to Participate in Upcoming March Events • PR Newswire (US) • 02/28/2024 12:30:00 PM
- FNB Harvest annonce les distributions de février 2024 • Business Wire • 02/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:43:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:43:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:42:03 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 01:47:01 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:48:34 PM
- Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference • PR Newswire (US) • 02/06/2024 12:30:00 PM
- FNB Harvest annonce les distributions de janvier 2024 • Business Wire • 01/24/2024 12:30:00 PM
- Trevi Therapeutics Provides Business Updates • PR Newswire (US) • 01/04/2024 12:30:00 PM
- FNB Harvest annonce les distributions annuelles finales réinvesties pour 2023 • Business Wire • 12/29/2023 03:26:00 PM
- FNB Harvest Distributions réinvesties annuelles estimatives révisées pour 2023 • Business Wire • 12/21/2023 09:33:00 PM
- FNB Harvest annonce les distributions de décembre 2023 • Business Wire • 12/18/2023 12:30:00 PM
- Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF) • PR Newswire (US) • 12/05/2023 12:30:00 PM
- FNB Harvest Distributions réinvesties annuelles estimées pour 2023 • Business Wire • 11/30/2023 08:14:00 PM
- FNB Harvest annonce les distributions de novembre 2023 • Business Wire • 11/17/2023 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:13:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM